European Journal of Vascular & Endovascular Surgery
Volume 36, Issue 3 , Pages 273-280 , September 2008

Potential Circulating Biomarkers for Abdominal Aortic Aneurysm Expansion and Rupture - a Systematic Review

  • S. Urbonavicius

      Affiliations

    • Vascular Research Unit, Department of Vascular Surgery, Viborg Hospital, Denmark
    • Institute of Medical Biochemistry of Aarhus University, Denmark
    • Corresponding Author InformationCorresponding author. S. Urbonavicius MD, Vascular Research Unit, Department of Vascular Surgery, Viborg Hospital, Denmark. Tel.: +4560846760; fax: +45868804.
    • ,
  • G. Urbonaviciene

      Affiliations

    • Vascular Research Unit, Department of Vascular Surgery, Viborg Hospital, Denmark
    • ,
  • B. Honoré

      Affiliations

    • Institute of Medical Biochemistry of Aarhus University, Denmark
    • ,
  • E.W. Henneberg

      Affiliations

    • Vascular Research Unit, Department of Vascular Surgery, Viborg Hospital, Denmark
    • ,
  • H. Vorum

      Affiliations

    • Institute of Medical Biochemistry of Aarhus University, Denmark
    • ,
  • J.S. Lindholt

      Affiliations

    • Vascular Research Unit, Department of Vascular Surgery, Viborg Hospital, Denmark

Received 20 November 2007 ,Accepted 14 May 2008.

References 

  1. Schermerhorn ML, Cronenwett JL. The UK small aneurysm trial. J Vasc Surg. 2001 Feb;33(2):443
  2. Lederle FA, Johnson GR, Wilson SE, Ballard DJ, Jordan WD, Blebea J, et al. Rupture rate of large abdominal aortic aneurysms in patients refusing or unfit for elective repair. JAMA. 2002 Jun 12;287(22):2968–2972
  3. Cornuz J, Sidoti PC, Tevaearai H, Egger M. Risk factors for asymptomatic abdominal aortic aneurysm: systematic review and meta-analysis of population-based screening studies. Eur J Public Health. 2004 Dec;14(4):343–349
  4. Lederle FA, Johnson GR, Wilson SE, Chute EP, Hye RJ, Makaroun MS, et al. The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Arch Intern Med. 2000 May 22;160(10):1425–1430
  5. Becker RC. Emerging paradigms, platforms, and unifying themes in biomarker science. J Am Coll Cardiol. 2007 Oct 30;50(18):1777–1780
  6. Limet R, Sakalihassan N, Albert A. Determination of the expansion rate and incidence of rupture of abdominal aortic aneurysms. J Vasc Surg. 1991 Oct;14(4):540–548
  7. Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet. 2005 Apr 30;365(9470):1577–1589
  8. Hance KA, Tataria M, Ziporin SJ, Lee JK, Thompson RW. Monocyte chemotactic activity in human abdominal aortic aneurysms: role of elastin degradation peptides and the 67-kD cell surface elastin receptor. J Vasc Surg. 2002 Feb;35(2):254–261
  9. Lindholt JS, Heickendorff L, Henneberg EW, Fasting H. Serum-elastin-peptides as a predictor of expansion of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 1997 Jul 1;14(1):12–16
  10. Lindholt JS, Ashton HA, Heickendorff L, Scott RAP. Serum elastin peptides in the preoperative evaluation of abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2001 Dec;22(6):546–550
  11. Petersen E, Gineitis A, Wagberg F, Angquist KA. Serum levels of elastin-derived peptides in patients with ruptured and asymptomatic abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2001 Jul;22(1):48–52
  12. Lindholt JS, Heickendorff L, Vammen S, Fasting H, Henneberg EW. Five-year results of elastin and collagen markers as predictive tools in the management of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2001 Mar;21(3):235–240
  13. Satta J, Haukipuro K, Kairaluoma MI, Juvonen T. Aminoterminal propeptide of type III procollagen in the follow-up of patients with abdominal aortic aneurysms. Journal of Vascular Surgery. 1997 May;25(5):909–915
  14. Treska V, Topolcan O. Plasma and tissue levels of collagen types I and III markers in patients with abdominal aortic aneurysms. Int Angiol. 2000 Mar;19(1):64–68
  15. Wilson KA, Lindholt JS, Hoskins PR, Heickendorff L, Vammen S, Bradbury AW. The relationship between abdominal aortic aneurysm distensibility and serum markers of elastin and collagen metabolism. Eur J Vasc Endovasc Surg. 2001;21(2):175–178
  16. Claridge MW, Hobbs SD, Quick CR, Day NE, Bradbury AW, Wilmink AB. ACE inhibitors increase type III collagen synthesis: a potential explanation for reduction in acute vascular events by ACE inhibitors. Eur J Vasc Endovasc Surg. 2004 Jul;28(1):67–70
  17. Lindholt JS, Vammen S, Fasting H, Henneberg EW, Heickendorff L. The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study. Eur J Vasc Endovasc Surg. 2000 Sep;20(3):281–285
  18. Hovsepian DM, Ziporin SJ, Sakurai MK, Lee JK, Curci JA, Thompson RW. Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease. J Vasc Interv Radiol. 2000 Nov;11(10):1345–1352
  19. Eugster T, Huber A, Obeid T, Schwegler I, Gurke L, Stierli P. Aminoterminal propeptide of type III procollagen and matrix metalloproteinases-2 and -9 failed to serve as serum markers for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2005 Apr;29(4):378–382
  20. Lindholt JS, Jorgensen B, Klitgaard NA, Henneberg EW. Systemic levels of cotinine and elastase, but not pulmonary function, are associated with the progression of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2003 Oct;26(4):418–422
  21. Shi GP, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT, et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest. 1999 Nov;104(9):1191–1197
  22. Lindholt JS, Erlandsen EJ, Henneberg EW. Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms. Br J Surg. 2001 Nov;88(11):1472–1475
  23. Lindholt JS, Jorgensen B, Fasting H, Henneberg EW. Plasma levels of plasmin-antiplasmin-complexes are predictive for small abdominal aortic aneurysms expanding to operation-recommendable sizes. J Vasc Surg. 2001 Oct;34(4):611–615
  24. Lindholt JS, Jorgensen B, Shi GP, Henneberg EW. Relationships between activators and inhibitors of plasminogen, and the progression of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2003 Jun;25(6):546–551
  25. Lindholt JS. Activators of plasminogen and the progression of small abdominal aortic aneurysms. Ann N Y Acad Sci. 2006 Nov;1085:139–150
  26. Yamazumi K, Ojiro M, Okumura H, Aikou T. An activated state of blood coagulation and fibrinolysis in patients with abdominal aortic aneurysm. Am J Surg. 1998 Apr;175(4):297–301
  27. Al-Barjas HS, Ariens R, Grant P, Scott JA. Raised plasma fibrinogen concentration in patients with abdominal aortic aneurysm. Angiology. 2006 Oct;57(5):607–614
  28. Juvonen J, Surcel HM, Satta J, Teppo AM, Bloigu A, Syrjala H, et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2843–2847
  29. Treska V, Topolcan O, Pecen L. Cytokines as plasma markers of abdominal aortic aneurysm. Clin Chem Lab Med. 2000 Nov;38(11):1161–1164
  30. Treska V, Wenham PW, Valenta J, Topolcan O, Pecen L. Plasma endothelin levels in patients with abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 1999;17(5):424–428
  31. Jones KG, Brull DJ, Brown LC, Sian M, Greenhalgh RM, Humphries SE, et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation. 2001 May 8;103(18):2260–2265
  32. Pan JH, Lindholt JS, Sukhova GK, Baugh JA, Henneberg EW, Bucala R, et al. Macrophage migration inhibitory factor is associated with aneurysmal expansion. J Vasc Surg. 2003 Mar;37(3):628–635
  33. Golledge J, Muller J, Shephard N, Clancy P, Smallwood L, Moran C, et al. Association between osteopontin and human abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 2006 Dec 14;
  34. Moran CS, McCann M, Karan M, Norman P, Ketheesan N, Golledge J. Association of osteoprotegerin with human abdominal aortic aneurysm progression. Circulation. 2005 Jun 14;111(23):3119–3125
  35. Norman P, Spencer CA, Lawrence-Brown MM, Jamrozik K. C-reactive protein levels and the expansion of screen-detected abdominal aortic aneurysms in men. Circulation. 2004 Aug 17;110(7):862–866
  36. Lindholt JS, Heegaard NHH, Vammen S, Fasting H, Henneberg EW, Heickendorff L. Smoking, but not lipids, lipoprotein (a) and antibodies against oxidised LDL, is correlated to the expansion of abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2001;21(1):51–56
  37. Vainas T, Stassen FR, de GR, Twiss EL, Herngreen SB, Welten RJ, et al. C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events. J Vasc Surg. 2005 Aug;42(2):243–251
  38. Domanovits H, Schillinger M, Mullner M, Holzenbein T, Janata K, Bayegan K, et al. Acute phase reactants in patients with abdominal aortic aneurysm. Atherosclerosis. 2002 Aug;163(2):297–302
  39. Brunelli T, Prisco D, Fedi S, Rogolino A, Farsi A, Marcucci R, et al. High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. J Vasc Surg. 2000 Sep;32(3):531–536
  40. Halazun KJ, Bofkin KA, Asthana S, Evans C, Henderson M, Spark JI. Hyperhomocysteinaemia is associated with the rate of abdominal aortic aneurysm expansion. Eur J Vasc Endovasc Surg. 2006 Dec 9;
  41. Lindholt JS, Juul S, Vammen S, Lind I, Fasting H, Henneberg EW. Immunoglobulin A antibodies against Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysm. Br J Surg. 1999 May;86(5):634–638
  42. Lindholt JS, Ashton HA, Scott RA. Indicators of infection with Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysms. J Vasc Surg. 2001 Aug;34(2):212–215
  43. Falkensammer B, Duftner C, Seiler R, Pavlic M, Walder G, Wilflingseder D, et al. Lack of microbial DNA in tissue specimens of patients with abdominal aortic aneurysms and positive Chlamydiales serology. Eur J Clin Microbiol Infect Dis. 2007 Jan 11;
  44. Nyberg A, Skagius E, Nilsson I, Ljungh A, Henriksson AE. Lack of association between Chlamydophila pneumoniae seropositivity and abdominal aortic aneurysm. Vasc Endovascular Surg. 2007 Jun;41(3):246–248

PII: S1078-5884(08)00291-8

doi: 10.1016/j.ejvs.2008.05.009

European Journal of Vascular & Endovascular Surgery
Volume 36, Issue 3 , Pages 273-280 , September 2008

Article Tools